In Longwood Medical Area, jobs were being added about twice as fast as in the state overall
A study says employment in Bostonâs medical hub grew nearly 30% from 2008 to 2019
By Jon Chesto Globe Staff,Updated May 3, 2021, 3:51 p.m.
Email to a Friend
Medical employees and others make their way across Brookline Avenue. A study of Longwood Medical Area s growth suggests transit improvements might benefit the area.David L. Ryan/Globe Staff
Longwood Medical Area has come a long way from the days when Boston Childrenâs Hospital set up shop on Huntington Avenue with 60 beds and a herd of cows to provide kids with tuberculosis-free milk.
A startup finds its footing during the pandemic
By Scott Kirsner Globe Correspondent,Updated May 2, 2021, 1 hour ago
Email to a Friend
While quarantining in Chester, Vt., over the winter, Cohere Health cofounder Duncan Reece brought a set of new MacBooks with him to configure and send to new hires.Cohere Health
On the last day of March, Duncan Reece put on an N95 face mask and headed to downtown Boston to meet five colleagues. Their objective was to check out four offices to see if one might be right for their fast-growing startup, Cohere Health.
When the pandemic arrived a year before, Cohere had 16 employees and operated out of a shared office space in Downtown Crossing. By this March, Cohere, which focuses on smoothing out the process of getting âprior authorizationsâ for doctorâs appointments and medical procedures, had grown to 160 people â all of them working remotely. The topic of needing some sort of office space by July or August had come up, leading
Kim Janey was sworn in as acting mayor of Boston on March 24. She is also one of eight candidates running to be elected as Boston s next mayor in November s municipal election. So, is there a difference between the office she currently holds and the one she seeks? The short answer is yes. As for how they differ? It s complicated.
Janey became the acting mayor because she was serving as president of the Boston City Council at the time of Marty Walsh s departure, as prescribed in the Boston city charter. Section 11B reads in part, whenever there is a vacancy in the office of mayor from any cause, the president of the city council, while such absence, inability or vacancy continues, shall perform the duties of mayor.”
By Grant Welker
A firm making gene therapy for rare diseases that was co-founded by a UMass Medical School professor has won regulatory approval to continue research and investigatory work for an ALS therapy.
Apic Bio, now based in Cambridge s Kendall Square, was co-founded by Dr. Robert Brown Jr., a professor in UMass neurology department. Brown was a lead member of the team that discovered a particular enzyme as the first genetic mutation linked to ALS, or amyotrophic lateral sclerosis.
The new therapy whose investigational new drug application was approved by the U.S. Food and Drug Administration began nearly 30 years ago with the gene therapy research conducted by Brown and others. The therapy, whose approval Apic Bio announced April 21, is aimed at slowing or reversing the progression of ALS, a disease also known as Lou Gehrig s disease with no cure and whose cause is unknown.
We now know the name of the restaurant thatâs opening atop the Newbury
Plus: A fish house comes to Bay Village, and New York ramen hits the suburbs
By Kara Baskin Globe Correspondent,Updated April 30, 2021, 8:13 a.m.
Email to a Friend
Coming soon: Major Food Group, the team behind lavish New York City destinations such as
Carbone,
Contessa atop the Newbury Boston (3 Newbury St.) in June.
A release promises a rooftop restaurant inspired by the âOld World resorts of Europe,â with Public Garden views. Expect an Italian menu (
Carbone is known for 1950s-style red-sauce dishes); this is their first local venture.